Exploring how complement proteins affect kidney disease in diabetes
Understanding the role of the Complement Proteome in progressive Diabetic Kidney Disease
['FUNDING_R01'] · JOSLIN DIABETES CENTER · NIH-10809603
This study is looking at how certain proteins in your urine might help us understand and track kidney problems in people with diabetes, with the hope of finding new ways to protect your kidneys from damage.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JOSLIN DIABETES CENTER (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10809603 on ClinicalTrials.gov |
What this research studies
This research investigates the role of complement proteins in the progression of diabetic kidney disease (DKD). By analyzing urine samples from patients with diabetes, the study aims to identify specific inflammatory markers that could indicate the risk of developing end-stage renal disease (ESRD). The researchers will use advanced proteomic technology to evaluate the urinary complement proteome over a long-term follow-up period. This approach may help uncover new targets for interventions to slow or prevent kidney damage in diabetic patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetes who are experiencing or at risk of developing diabetic kidney disease.
Not a fit: Patients without diabetes or those who do not have any signs of kidney disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent or slow the progression of kidney disease in patients with diabetes.
How similar studies have performed: Previous studies have shown promise in identifying inflammatory markers related to diabetic kidney disease, suggesting that this approach may yield valuable insights.
Where this research is happening
BOSTON, UNITED STATES
- JOSLIN DIABETES CENTER — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: NIEWCZAS, MONIKA ANNA — JOSLIN DIABETES CENTER
- Study coordinator: NIEWCZAS, MONIKA ANNA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: diabetes, Diabetes Mellitus, Diabetic Kidney Disease